It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
Why did a $72 million mission to study water on the moon fail so soon after launch? A new NASA report has the answer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results